Panagel, Frenchis M.

HRN: 10-76-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2023
AMPICILLIN 500MG (VIAL)
07/12/2023
07/18/2023
IVT
500 Mg
Q6
Uti
Waiting Final Action 
07/12/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/12/2023
07/18/2023
PO
7 Ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: